nialamide has been researched along with Hypoglycemia in 2 studies
Nialamide: An MAO inhibitor that is used as an antidepressive agent.
Hypoglycemia: A syndrome of abnormally low BLOOD GLUCOSE level. Clinical hypoglycemia has diverse etiologies. Severe hypoglycemia eventually lead to glucose deprivation of the CENTRAL NERVOUS SYSTEM resulting in HUNGER; SWEATING; PARESTHESIA; impaired mental function; SEIZURES; COMA; and even DEATH.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nowicka, H | 1 |
| Bargiel, Z | 1 |
| Wasilewska, E | 1 |
| Lundquist, I | 1 |
| Ekholm, R | 1 |
| Ericson, LE | 1 |
2 other studies available for nialamide and Hypoglycemia
| Article | Year |
|---|---|
Effect of nialamide and reserpin on catecholamine content in rat adrenal medulla after electrically provoked hypoglycemic convulsions.
Topics: Adrenal Medulla; Animals; Catecholamines; Electric Stimulation; Hypoglycemia; Nialamide; Rats; Reser | 1978 |
Monoamines in the pancreatic islets of the mouse. 5-hydroxytryptamine as an intracellular modifier of insulin secretion, and the hypoglycaemic action of monoamine oxidase inhibitors.
Topics: 5-Hydroxytryptophan; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Female; Glucose; Glybu | 1971 |